Posttranslational modi fi cation (PTM) by the covalent conjugation of small ubiquitin-like modi fi er (SUMO) plays an important role in many biological processes, such as cell cycle progression, transcriptional regulation, subcellular transport, and other processes. An in-depth understanding of the function of SUMOylation requires the discovery of SUMO accepter sites. However, identi fi cation of endogenous SUMO-conjugated sites in higher eukaryotes by MS-based proteomic strategies is hampered by the low abundance of SUMO conjugates, the large tryptic fragments of SUMO1 or SUMO2/3 and the inability to match MS/MS spectra by protein database search engine. In this chapter, we describe a powerful method to overcome at least some of these challenges. To identify SUMO acceptor sites in endogenous SUMO1 conjugated protein, the SUMO1 conjugates are puri fi ed by immunoprecipitation with anti-SUMO1 antibodies followed by SDS-PAGE separation and in-gel tryptic digestion. The resulting peptides are either performed using standard data dependent acquisition (DDA) for protein identi fi cation or high mass DDA to enhance the sensitivity of detection on the LTQ-Orbitrap mass spectrometer. Finally, a Web-based database tool, ChopNSpice, coupled with a protein database search engine is introduced to ease the identi fi cation of SUMO1 attachment sites. Although this method was initially used to identify SUMO1 accepter sites, it can be readily adapted to study SUMO2/3 conjugates or even other Ubiquitin-like modi fi ers.
analysis, and identi fi cation of PTMs in proteins (for summary see Chapter 7 ), including phosphorylation (see Chapters 21 and 22 ), glycosylation (see Chapter 23 ), oxidation (see Chapter 24 ), nitrosylation (see Chapter 25 ) acetylation, ubiquitylation (see Chapter 26 ) and SUMOylation (1) (2) (3) (4) . However, the enormous complexity of the proteome and the large dynamic range of protein expression impede the analysis of PTMs by MS. The small ubiquitin-like modi fi er (SUMO) proteins are members of the ubiquitin-like family of proteins that are reversible posttranslational modi fi ers. Covalent conjugation of SUMO to its targets requires the attachment of the C-terminal glycine residue of SUMO to the e -amino group of a lysine residue in the target protein. The modi fi cation of the target by SUMO subsequently regulates protein-protein interaction, or intra-molecular interactions, emerging as an important regulatory mechanism in a diverse range of cellular processes (5) (6) (7) (8) (9) .
Global proteomic approaches to identify novel SUMO substrates from yeast Saccharomyces cerevisiae have begun to emerge in recent years (10) (11) (12) (13) . These studies generally rely upon af fi nity puri fi cation of SUMOylated proteins from yeast S. cerevisiae , followed by the identi fi cation of SUMO accepter sites using mass spectrometric techniques. The presence of amino acid sequence (-EQIGG) on the modi fi ed lysine residue after digestion of the SUMO conjugates by trypsin leads to a 484-Da increase in the mass of the peptide that can be readily measured by mass spectrometry. The MS/MS spectra of these SUMOconjugated peptides can be identi fi ed by a protein database search that considers for this mass shift (484 Da) on the modi fi ed lysine residue. Unfortunately, such strategies are dif fi cult to be applied for the identi fi cation of SUMO accepter sites in mammalians due to the larger distance of Arg or Lys residue to the C terminus of mammalian SUMO-1, -2, and -3. As a consequence, the large SUMO-conjugated peptides from mammalians that are generated after trypsin digestion impede their identi fi cation by database searches. Identi fi cation of such large conjugated peptides using MS/MS spectra is only possible as the peptides of substrates within the protein database are also modi fi ed by SUMO sequence. ChopNSpice ( 4 ) is a powerful software tool to automatically generate SUMO-conjugated sequences of proteins in silico that is compatible with current proteomics search engines such as Mascot ( 14 ) or SEQUEST ( 15 ) (see Chapter 28 ) for the identi fi cation of SUMO accepter sites.
In this chapter, we describe a method for identifying SUMOylation sites isolated from HeLa-S3 cells using LTQOrbitrap mass spectrometry. The general work fl ow for globally mapping human endogenous SUMO1 accepter sites is depicted in Fig. 1 . Brie fl y, the puri fi cation of human SUMO1 conjugates is carried out by an immunoprecipitation with a -SUMO1 antibodies are merged into single peak list fi le for further protein database search. The proteins of interest are put into ChopNSpice software to create virtual SUMOylated protein sequences. The merging peak list fi le is resubmitted to search against modi fi ed protein database for identi fi cation of SUMO-conjugated sites.
1. Joklik's medium (Sigma-Aldrich, St. Louis, MO). 11. Monoclonal a -SUMO1 antibodies (GMP1, Zymed, South San Francisco, CA).
12. Protein G-agarose (GE Healthcare, Chalfont, UK).
13. Washing buffer: 20 mM NaP (pH 7.4), 150 mM NaCl, 1% Triton, 0.5% sodium deoxycholate, 0.1% SDS, 10 mM NEM.
14. Elution buffer: 2× SDS sample buffer. To identify the modi fi cation for the ubiquitin-like proteins of interest requires the puri fi cation of the entire pool of conjugates, in our case SUMO1, from the cell line of choice. Subsequently the conjugates are separated by SDS-PAGE, digested with trypsin, the peptide components of that mixture are analyzed using nanoLCOrbitrap mass spectrometry and fi nally the SUMO1-conjugated sites are identi fi ed using the Mascot search engine integrated with ChopNSpice software.
1. Maintain HeLa-S3 cells in Joklik's medium containing 10% fetal bovine serum and antibiotics.
2. Wash HeLa-S3 cells (1 × 10 9 ) twice with PBS containing 10 mM NEM. 11. Separate the eluted proteins by SDS-PAGE followed by Coomassie blue staining (see Note 2 and Chapter 4 ).
Excise entire lane from SDS-PAGE into 20 gel slices (see Note 3).
2. Cut each slice into pieces of 1 × 1 mm using a scalpel and a spatula and transfer these pieces into 0.5-ml Eppendorf tube for tryptic digestion.
3. Wash the gel pieces with 400 m L ABC, spin the gel pieces down and remove all liquid.
4. Add 400 m L ACN to shrink the gel pieces, spin the gel pieces down and remove all liquid.
5. Add 60 m L DDT solution to reduce the disul fi des and incubate in a thermomixer for 1 h at 37°C.
6. Spin the gel pieces down and remove all liquid.
7. Add 400 m L ACN to shrink the gel pieces, spin the gel pieces down and remove all liquid.
8. Add 60 m L IAA solution to alkylate the reduced cysteines and incubate in a thermomixer for 1 h at 37°C.
9. Repeat steps 6 and 7.
10. Add 60 m L trypsin solution (0.01 m g/ m L) to digest proteins and incubate in a thermomixer at least for 16 h at 37°C (see Note 4).
11. Add 100 m L ACN to shrink the gel pieces, spin the gel pieces down and transfer all liquid to the other 0.5-ml Eppendorf tube.
12. Add 60 m L extraction buffer, vortex for 10 s, sonicate for 1 min, spin the gel pieces down, and transfer all liquid to the corresponding Eppendorf tube.
13. Repeat step 12 three times.
14. Add 60 m L ACN to shrink the gel pieces, spin the gel pieces down and transfer all liquid to the corresponding Eppendorf tube.
15. Repeat step 14.
Tryptic Digest of SUMO1 Conjugates and Extraction of SUMO1-Conjugated Peptides
16. Dry down the supernatant with a SpeedVac.
17. Store the dried sample at −20°C for further MS analysis.
All NanoLC-MS/MS analyses were performed on a LTQ-Orbitrap XL mass spectrometer equipped with a nanoLC ESI source, connected to an Agilent 1100 LC system with an autosampler under the software control of Xcalibur 2.0.7. 3. NanoLC conditions: Following autosampler injection, the gradient was fi rst held at 100% mobile phase A for 5 min, raised a 0.5 min linear gradient from 0 to 7.5% mobile phase B, a 37 min linear gradient from 7.5 to 37.5% mobile phase B, a 0.5 min linear gradient from 37.5 to 80% mobile phase B, 7 min at 80% mobile phase B, a 0.5 min linear gradient to 100% mobile phase A and fi nally held at 100% mobile phase A for 9.5 min.
In this step, parts of tryptic peptides separated by nanoLC are introduced into LTQ-Orbitrap MS through nanoelectrospray ion source. For protein identi fi cation, the eluted peptide ions are analyzed in a standard data-dependent acquisition. First, the m/z values of the peptides are detected and the most fi ve intense ions are selected for collision-induced dissociation (CID) MS/MS, in which a peptide is fragmented in turn. The MS/MS spectra contain the peptide sequence information and are used to search protein database for protein identi fi cation. In addition, the remains of tryptic peptides are performed with high mass data-dependent acquisition. Under this condition, only peptides with a mass exceeding SUMO are triggered for MS/MS acquisition. This approach is highly sensitive for the detection and sequencing of larger SUMO conjugated-peptides.
1. Operate the LTQ-Orbitrap MS in the standard data-dependent acquisition to automatically trigger MS/MS scan by using the Tune and Xcalibur 2.0.7. software. 4. For high mass data-dependent acquisition, the settings are identical to standard data-dependent acquisition in addition to the followed parameters in the Xcalibur software.
(a) Set an additional three microscans in LTQ MS/MS scan.
(b) The mass range for selecting MS-data-dependent masses was set 2,154-1,000,000 for SUMO1-conjugated peptides, and the option of m/z value as masses had to be enabled (see Note 6).
Peak list fi les (mgf format) are generated from MS raw data by Bioworks browser, containing precursor masses and their corresponding product ion masses and intensities. The mgf fi le is used to match peptide sequence information by the Mascot search engine for protein identi fi cation. The proteins of interest are put into ChopNSpice software to create a new protein database. The search is repeated against the modi fi ed protein database and the SUMO acceptor sites can be identi fi ed.
1. Convert MS/MS spectra from the raw LC/MS/MS data fi le to single mgf fi le using Bioworks browser (see Note 7).
2. Submit mgf fi le to Mascot search engine for protein identi fi cation with the following parameters: trypsin speci fi city; allow up to two missed cleavages; consider methionine oxidation and cysteine carboxyamidomethylation as variable modi fi cations; instrument setting ESI-TRAP; mass tolerance of 10 ppm in MS mode and 0.8 Da in MS/MS mode.
3. The sequence of the protein of interest was manually saved as a Fasta fi le.
Data Analysis and Identi fi cation of SUMOylation Site
SUMO1-conjugated peptides. High percentage of organic solvent and sonication are essential to redissolve those large peptides.
6. Increase of additional microscans can improve the quality of MS/MS spectrum for mapping SUMO1-conjugated sites via database searching and high mass data-dependent acquisition enhance the sensitivity to identify the acceptor sites from more complex sample.
7. Mascot does not support to search MS/MS fragment ions with a charge state higher than 2, resulting in larger SUMO1-conjugated peptides with charge state of +4 or +5 show a low Mascot score or are not identi fi ed at all. MS/MS spectra recorded in the FT analyzer/detector of the Orbitrap MS with suf fi cient resolution for charge-state recognition have to use software tool Raw2msn ( 16 ) to deconvolute the higher charge stages of the fragment ions in the raw data to singly charged fragment ions for Mascot search that in turn increase the identi fi cation.
8.
A new enzyme allowed cutting J at both C and N terminus have to be created in Mascot server. The fi le "quant_subs.pl" in the folder (mascot\cgi\) must be changed from J ³ 0 to J ³ 0.05 in line 3653. In addition, SUMO-conjugated sites also can be identi fi ed by using other search engines e.g., SEQUEST, X!Tandem, etc.
